4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001019056-22-000112
SVP and CFO acquired 1,833 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lamothe Jeffrey G. SVP and CFO | 2022-01-29 | Option exercise | +1,833 | 7,192 | D | ||
| Derivatives | |||||||
| Lamothe Jeffrey G. SVP and CFO | 2022-01-29 | Option exercise · Restricted Stock Unit | +1,833 | 3,667 | D | ||
Loading xslF345X03/lamothe.xml…